A Study of Tocilizumab (RoActemra/Actemra) in Monotherapy or in Combination With Methotrexate or Other Non-Biologic DMARDs in Participants With Active Rheumatoid Arthritis and an Inadequate Response to Current Non-Biologic DMARD Therapy or the First Anti-TNF Biologic Agent
Clinical trial NCT02046603 · COMPLETED
Trial details
- NCT number
- NCT02046603
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-04
- Primary completion
- 2016-08-04
- Enrollment
- 162
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.